Published: Tuesday, December 23, 2014
Nicox to concentrate resources on its growing pipeline of ophthalmic therapeutics following recent acquisition of Aciex Therapeutics, Inc.
• Transaction worth up to $20 million, including $10 million upfront plus potential sales-based milestone payments of up to $10 million
Published: Friday, December 12, 2014
Immco Diagnostics, A Trinity Biotech Company to exhibit at Arab Health held at the Dubai Conference and Exhibition Center in Dubai, UAE January 26-29, 2015. Visit Immco at Booth RA19 to see demonstrations of the Isight IFA, a digital image acquisition system for cell and tissue based indirect IFA, and our new product line of ImmcoStripe Line ImmunoAssays.
Published: Thursday, September 4, 2014
Immco Presented on several topics “IMPROVED QUALITATIVE AND QUANTITATIVE DIAGNOSTICS FOR DETERMINATION OF DFS70 AUTOANTIBODIES,” “QUANTITATION APPROACH FOR AUTOIMMUNE DIAGNOSTICS USING HIGHLY SENSITIVE AND SPECIFIC LINE IMMUNO ASSAYS,” and “LESSONS LEARNED FROM THE IL-14 ALPHA TRANSGENIC MOUSE MODEL FOR SJOGRENS SYNDROME.”
Published: Monday, August 11, 2014
A Mid-Sized Hospital System’s Approach to Implementing Current Guidelines for ANA Testing in Today’s Financial Climate, Thomas S. Alexander, Ph.D., D(AMMBLI), Summa Health System
Novel Antibodies in the Diagnosis of Sjogrens Syndrome, Julian Ambrus, Jr., M.D., University of Buffalo School of Medicine and Biomedical Sciences
Published: Thursday, May 8, 2014
Please visit Immco Diagnostics at the AACC Annual Meeting and Clinical Lab Expo to be held in Chicago, Illinois July 27-31, 2014. Immco will be exhibiting with Trinity Biotech in booth #4636 and will be offering demos of the Zenit UP ELISA and IFA processor as well as the Immco ISight IFA,
a state of the art digital image acquisition system.